Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 23317209)

1.

Role of nuclear factor-κB in female breast cancer: a study in Indian patients.

Jana D, Das S, Sarkar DK, Mandal S, Maji A, Mukhopadhyay M.

Asian Pac J Cancer Prev. 2012;13(11):5511-5.

2.

Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India.

Jana D, Mandal S, Mukhopadhyay M, Mitra D, Mukhopadhyay SK, Sarkar DK.

Asian Pac J Cancer Prev. 2012;13(8):3851-5.

3.
4.

Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients.

Sarkar DK, Jana D, Patil PS, Chaudhari KS, Chattopadhyay BK, Chikkala BR, Mandal S, Chowdhary P.

Indian J Surg Oncol. 2013 Sep;4(3):242-7. doi: 10.1007/s13193-013-0234-y. Epub 2013 Apr 25.

5.

The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer.

Hou MF, Lin SB, Yuan SS, Tsai SM, Wu SH, Ou-Yang F, Hsieh JS, Tsai KB, Huang TJ, Tsai LY.

Clin Chim Acta. 2003 Aug;334(1-2):137-44.

PMID:
12867284
6.

Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.

Shapochka DO, Zaletok SP, Gnidyuk MI.

Exp Oncol. 2012 Dec;34(4):358-63.

PMID:
23302996
7.

Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.

Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A.

Asian Pac J Cancer Prev. 2011;12(3):625-9.

8.

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.

Spizzo G, Obrist P, Ensinger C, Theurl I, Dünser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G, Gastl G.

Int J Cancer. 2002 Apr 20;98(6):883-8.

PMID:
11948467
9.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
10.
11.

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

Ann Surg Oncol. 1995 Sep;2(5):440-4.

PMID:
7496840
12.

Morphological profile and receptor status in breast carcinoma: an institutional study.

Rao C, Shetty J, Kishan Prasad HL.

J Cancer Res Ther. 2013 Jan-Mar;9(1):44-9. doi: 10.4103/0973-1482.110358.

13.

Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women.

Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Prasarttong Osoth P.

Asian Pac J Cancer Prev. 2012;13(2):459-62.

14.

FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.

15.

Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.

El-Hafez AA, El Aaty Shawky A, Hasan B.

Cancer Biomark. 2012;12(4):149-54. doi: 10.3233/CBM-130303.

PMID:
23568005
16.

Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.

Sharif MA, Mamoon N, Mushtaq S, Khadim MT.

J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103. doi: 02.2009/JCPSP.99103.

PMID:
19208313
17.

Do we need HER-2/neu testing for all patients with primary breast carcinoma?

Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.

Cancer. 2003 Dec 15;98(12):2547-53.

18.

Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.

Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, Spina D, Bellan C, Lazzi S, Kostopoulos I, Luzi P, Leoncini L.

Anal Quant Cytol Histol. 2006 Apr;28(2):97-103.

PMID:
16637512
19.

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.

Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.

Breast J. 2005 Jul-Aug;11(4):278-80.

PMID:
15982396
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk